ACIP Majority Ignores Risks and Recommends Infants Get Merck’s RSV Monoclonal Antibody
On June 25, 2025, the majority of members of the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) ignored risk warnings and voted for a recommendation that infants be given Merck & Co.’s monoclonal antibody, clesrovimab, marketed as Enflonsia. The committee advised using Enflonsia to prevent Respiratory Syncytial Virus […]
AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event
News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]